HIV Drugs Market Share, Size, Global Industry Trends, Analysis, Opportunity and Forecast to 2027

According to IMARC Group's latest report, titled "𝗛𝗜𝗩 𝗗𝗿𝘂𝗴𝘀 𝗠𝗮𝗿𝗸𝗲𝘁: 𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗧𝗿𝗲𝗻𝗱𝘀, 𝗦𝗵𝗮𝗿𝗲, 𝗦𝗶𝘇𝗲, 𝗚𝗿𝗼𝘄𝘁𝗵, 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗮𝗻𝗱 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝟮𝟬𝟮𝟮-𝟮𝟬𝟮𝟳", the global HIV drugs market size reached US$ 29.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 38.9 Billion by 2027, exhibiting a CAGR of 3.7% during 2022-2027.

Human immunodeficiency virus (HIV) attacks the immune system, leaving the body susceptible to infections and other diseases. It is primarily transmitted through sexual or blood-to-blood contact, making it a significant public health concern globally. HIV drugs are essential in managing the disease and reducing its impact on patients, allowing them to lead longer and healthier lives. They work by inhibiting the replication of the virus, reducing the risk of transmission and progression of the disease. Currently, there are several types of HIV drugs available, including nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), integrase inhibitors, and entry inhibitors. These drugs can be administered through various methods, including pills, injections, and topical gels.

𝗚𝗲𝘁 𝗮 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁: https://www.imarcgroup.com/hiv-drug-market/requestsample

𝐍𝐨𝐭𝐞: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

HIV Drugs Market Trends:

The surging prevalence and diagnosis of HIV and the growing consumer awareness regarding the availability of HIV treatments are some of the primary factors accelerating the market growth. Additionally, governments of several nations are actively working to raise awareness regarding the symptoms, causes, and treatments of HIV, which, in turn, is creating a positive outlook for the market. Furthermore, the introduction of new, more effective antiretroviral drugs and burgeoning healthcare expenditures are positively contributing to the market growth. Other factors, such as rapid technological advancements, the introduction of generic drugs, and inflating expenditure on research and development (R&D) activities, are positively supporting the market growth.

Competitive Landscape With Key Players:

The competitive landscape of the HIV drugs market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Boehringer Ingelheim International GmbH,
• Merck & Co., Inc.,
• ViiV Healthcare,
• AbbVie, F. Hoffmann-La Roche Ltd.,
• Teva Pharmaceutical Industries Ltd.,
• Bristol-Myers Squibb Gilead Sciences, Inc.,
• Johnson & Johnson,
• Cipla Limited,
• Daiichi Sankyo,
• Emcure,
• Hetero Drugs,
• Mylan.

Key Market Segmentation:

The report has segmented the global HIV drugs market on the basis of breakup by drug class, distribution channel and region.

Breakup by Drug Class:

• Nucleoside Reverse Transcriptase Inhibitors
• Multi-Class Combination Products
• Protease Inhibitors
• HIV Integrase Strand Transfer Inhibitors
• Non-Nucleoside Reverse Transcriptase Inhibitors
• Entry Inhibitors - CCR5 Co-Receptor Antagonist
• Fusion Inhibitors and Others

Breakup by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Turkey, South Africa, Others)

𝗔𝘀𝗸 𝗔𝗻𝗮𝗹𝘆𝘀𝘁 𝗳𝗼𝗿 𝟭𝟬% 𝗳𝗿𝗲𝗲 𝗰𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲𝗱 𝗿𝗲𝗽𝗼𝗿𝘁: https://www.imarcgroup.com/request?type=report&id=953&flag=C

This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝗦:

IMARC Group

134 N 4th St Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

This release was published on openPR.